Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
de Gage, Sophie Billioti
35  Ergebnisse:
Personensuche X
?
1

Roll-out and effectiveness of HIV pre-exposure prophylaxis ..:

Billioti de Gage, Sophie ; Jourdain, Hugo ; Desplas, David.
Therapies.  78 (2023)  5 - p. 585-591 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Real-world effectiveness of pre-exposure prophylaxis in men..:

Jourdain, Hugo ; de Gage, Sophie Billioti ; Desplas, David.
The Lancet Public Health.  7 (2022)  6 - p. e529-e536 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Roll-out of HIV pre-exposure prophylaxis use in France: A n..:

Billioti de Gage, Sophie ; Desplas, David ; Dray-Spira, Rosemary
The Lancet Regional Health - Europe.  22 (2022)  - p. 100486 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Risk of Myocardial Infarction, Stroke, or Death in New User..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
Ophthalmology and Therapy.  11 (2022)  2 - p. 587-602 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Risk of Myocardial Infarction, Stroke, or Death in New User..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40123-021-00451-1.  , 2022
Link: https://hal.science/hal-..
 
?
6

Risk of Myocardial Infarction, Stroke, or Death in New User..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40123-021-00451-1.  , 2022
Link: https://hal.science/hal-..
 
?
7

Roll-out of HIV pre-exposure prophylaxis use in France: A n..:

Billioti de Gage, Sophie ; Desplas, David ; Dray-Spira, Rosemary
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386455/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Risk of Myocardial Infarction, Stroke, or Death in New User..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40123-021-00451-1.  , 2022
Link: https://hal.science/hal-..
 
?
9

Roll-out of HIV pre-exposure prophylaxis use in France: A n..:

Sophie Billioti de Gage ; David Desplas ; Rosemary Dray-Spira
http://www.sciencedirect.com/science/article/pii/S266677622200182X.  , 2022
Link: https://doi.org/10.1016/..
 
?
10

Dépistage et incidence du VIH après initiation d'une PrEP e..:

Tassi, M.F. ; Laurent, E. ; Gras, G....
Infectious Diseases Now.  51 (2021)  5 - p. S20 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Intravitreal anti‐VEGF use in France: a cross‐sectional and..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
Acta Ophthalmologica.  100 (2021)  2 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
12

PrEP monitoring and HIV incidence after PrEP initiation in ..:

Tassi, Marc-Florent ; Laurent, Emeline ; Gras, Guillaume...
Journal of Antimicrobial Chemotherapy.  76 (2021)  11 - p. 3002-3008 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Intravitreal anti‐VEGF use in France: a cross‐sectional and..:

Billioti de Gage, Sophie ; Bertrand, Marion ; Grimaldi, Sébastien.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291173/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Intravitreal anti-VEGF use in France: a cross-sectional and..:

Billioti de Gage, Sophie Billioti ; Bertrand, Marion ; Grimaldi, Sébastien.
info:eu-repo/semantics/altIdentifier/doi/10.1111/aos.14929.  , 2021
Link: https://hal.science/hal-..
 
?
15

Intravitreal anti-VEGF use in France: a cross-sectional and..:

Billioti de Gage, Sophie Billioti ; Bertrand, Marion ; Grimaldi, Sébastien.
info:eu-repo/semantics/altIdentifier/doi/10.1111/aos.14929.  , 2021
Link: https://hal.science/hal-..
 
1-15